Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1983-05-26
1984-12-18
Evans, J. E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2605005H, C07C 8310, A61K 31185
Patent
active
044890958
ABSTRACT:
The present invention relates to new industrial products, namely halogeno-benzhydrylsulfinylacetohydroxamic acids of formula: ##STR1## wherein: X.sub.1 is F, Cl, Br or CF.sub.3 ; and
REFERENCES:
patent: 2483671 (1949-10-01), Rieveschl
patent: 2618637 (1952-11-01), Archer et al.
patent: 3157650 (1964-11-01), Habicht
patent: 3549691 (1970-12-01), Leigh et al.
patent: 3789072 (1974-01-01), Bernstein
patent: 3993683 (1976-11-01), Nickl et al.
patent: 4013776 (1977-03-01), Lafon
patent: 4062973 (1977-12-01), Nickl et al.
patent: 4066686 (1978-01-01), Lafon
patent: 4122186 (1978-10-01), Lafon
patent: 4134996 (1979-01-01), Dunbar et al.
patent: 4156011 (1979-05-01), Lafon et al.
patent: 4177290 (1979-12-01), Lafon
patent: 4183927 (1980-01-01), Begin et al.
patent: 4199597 (1980-04-01), Neustadt et al.
Buraczewski, et al., Bull. Acad. Polon. Sci. Ser. Sci. Chim. vol. XII No. 11, 1964.
J. Org. Chem., vol. 32, Oct. 1967, pp. 3191-3194.
Evans J. E.
Laboratoire L. Lafon
LandOfFree
Halogenobenzhydrylsulfinylacetohydroxamic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Halogenobenzhydrylsulfinylacetohydroxamic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogenobenzhydrylsulfinylacetohydroxamic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988435